Hematocrit Levels on Testosterone Therapy

Physician-reviewed TRT safety education

High Hematocrit on Testosterone Therapy

Testosterone can raise hemoglobin and hematocrit. The key is not panic or automatic blood donation—it is identifying the cause, checking the level, and adjusting treatment appropriately.

Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

Why does testosterone raise hematocrit?

Testosterone stimulates red blood cell production through several mechanisms, including effects on erythropoietin and iron regulation. This is one of the most common laboratory changes seen during testosterone therapy. Hemoglobin and hematocrit often rise most during the first several months of treatment and may then plateau.

Some formulations appear more likely to raise hematocrit than others. The AUA guideline notes that injectable testosterone tends to produce larger increases in hemoglobin and hematocrit than many transdermal formulations, likely in part because injections can produce higher peak testosterone levels.

Read more about testosterone replacement therapy and our comparison of testosterone cypionate vs. enanthate.

What hematocrit level is considered too high on TRT?

Laboratory reference ranges vary, but TRT-specific treatment decisions are not based only on whether a result is flagged “high” by the lab. The AUA defines polycythemia/erythrocytosis generally as hematocrit above 52% and recommends intervention when hematocrit reaches 54% or higher during testosterone therapy.

That 54% threshold is a management trigger used in major testosterone guidelines; it should not be interpreted as a precise line where risk suddenly changes from safe to dangerous. Clinical context matters, including symptoms, rate of rise, testosterone concentration, sleep-disordered breathing, smoking, altitude and other medical conditions.

What should happen if hematocrit reaches 54%?

Contact the prescribing clinician promptly when hematocrit reaches 54% or higher; do not wait for the next routine annual review. The clinician should determine why it is elevated and whether the testosterone regimen is contributing. The AUA recommends dose adjustment as first-line management when hematocrit is elevated and on-treatment testosterone is also high. If total testosterone looks low or normal, clinicians may need to review free testosterone and SHBG before deciding whether the dose is truly appropriate.

If hematocrit remains elevated despite low or normal total and free testosterone—or if another hematologic disorder is suspected—hematology evaluation may be appropriate. Phlebotomy can be used in selected cases, but it should be part of a clinical plan rather than an automatic standing instruction for everyone on TRT.

Should men on TRT routinely donate blood?

No. Routine blood donation should not be treated as a substitute for evaluating the cause of erythrocytosis. Donation or therapeutic phlebotomy may lower hematocrit, but repeated blood removal can also affect iron stores. If hematocrit is repeatedly elevated, the testosterone dose, formulation, blood level and other causes should be reviewed instead of simply scheduling indefinite blood draws.

The AUA specifically places dose adjustment ahead of phlebotomy in many men with high on-treatment testosterone levels.

Does dehydration cause a high hematocrit?

Dehydration can temporarily concentrate the blood and make hematocrit appear higher. Rechecking an unexpected result when the patient is normally hydrated may be reasonable. However, drinking extra water is not a treatment for true testosterone-induced erythrocytosis. Persistent elevation should be evaluated on its own merits.

What other conditions can raise hematocrit?

Not every high hematocrit in a man on TRT is caused by testosterone. Other causes can include obstructive sleep apnea, smoking, chronic lung disease, hypoxia, living at high altitude, certain kidney or tumor-related conditions, and primary hematologic disorders such as polycythemia vera.

This is one reason a clinician should not assume the answer is simply “lower the dose” or “donate blood” without looking at the broader clinical picture.

Does a high hematocrit increase clot or cardiovascular risk?

Higher blood viscosity is biologically concerning, and observational data have linked testosterone-associated erythrocytosis with increased cardiovascular or thrombotic events in some populations. However, the exact hematocrit level at which risk rises and how much of that risk is directly caused by testosterone-induced erythrocytosis remain areas of ongoing study.

The practical takeaway is that elevated hematocrit should be taken seriously and managed according to guideline-based thresholds rather than ignored.

How often should hematocrit be checked on TRT?

The Endocrine Society recommends checking hematocrit before treatment, at 3–6 months after starting, and then annually. A clinician may check sooner or more often when results are rising, treatment changes or other risks warrant it. The exact interval depends on the patient's baseline values, formulation, dose, age, medical history and prior trend. Men who previously developed erythrocytosis generally warrant closer monitoring.

A CBC is commonly used to track hemoglobin and hematocrit along with other blood-cell measurements. See our guide to blood tests for testosterone therapy.

Can changing the testosterone formulation help?

Sometimes. Because injectable preparations can produce higher peaks and larger hematocrit increases in some men, changing the dose, dosing strategy or formulation may reduce erythrocytosis. This should be individualized rather than handled with a one-size-fits-all protocol.

Any dose or formulation change should be followed by repeat laboratory monitoring and symptom assessment.

What about grapefruit, low-iron diets or supplements?

These are not standard evidence-based treatments for testosterone-induced erythrocytosis. An older small study explored grapefruit and hematocrit, but that does not support recommending grapefruit as routine management for men on TRT. Likewise, deliberately restricting dietary iron without a specific indication can create other problems.

The more reliable approach is to identify the cause, adjust the testosterone regimen when appropriate, evaluate contributing conditions and use phlebotomy selectively when clinically indicated.

Frequently asked questions

Is a hematocrit of 52% dangerous on TRT?

A hematocrit above 52% is often considered erythrocytosis, but the AUA's intervention threshold during TRT is 54%. A value of 52% still deserves attention to trend, testosterone level and contributing risk factors.

Should TRT be stopped at 54%?

Management should be clinician-directed. Major guidance recommends intervention at 54%, which may include holding or reducing testosterone, evaluating contributing causes and restarting at an adjusted dose after the level normalizes.

Can sleep apnea make hematocrit worse?

Yes. Obstructive sleep apnea can cause intermittent hypoxia and contribute to erythrocytosis. Men with unexpectedly elevated hematocrit may need evaluation for sleep-disordered breathing depending on symptoms and risk factors.

Can splitting testosterone injections lower hematocrit?

Changing dose frequency can alter peak and trough testosterone levels, but it should not be assumed to solve erythrocytosis in every patient. The total dose, achieved testosterone level, formulation and individual response matter more than a single dosing trick.

Is phlebotomy always necessary?

No. It may be appropriate in selected cases, particularly with hematology involvement, but guideline-based management often begins with reassessing testosterone exposure and other causes.

Medical sources

• American Urological Association: Testosterone Deficiency Guideline
• Endocrine Society: Testosterone Therapy in Men With Hypogonadism
• Management of Erythrocytosis in Men Receiving Testosterone Therapy

This article is educational and does not replace individualized medical care. Abnormal hematocrit values should be interpreted and managed by an appropriately licensed clinician.